Cargando…
The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis: Erratum
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4697965/ http://dx.doi.org/10.1097/01.md.0000475936.88100.3b |
Ejemplares similares
-
The Risk of Neutropenia and Leukopenia in Advanced Non-Small Cell Lung Cancer Patients Treated With Erlotinib: A Prisma-Compliant Systematic Review and Meta-Analysis
por: Zhou, Jian-Guo, et al.
Publicado: (2015) -
Acupuncture and weight loss in Asians: A PRISMA-compliant systematic review and meta-analysis: Erratum
Publicado: (2019) -
Does pigtail catheters relieve pneumothorax?: A PRISMA-compliant systematic review and meta-analysis: Erratum
Publicado: (2019) -
Diagnostic accuracy of tumor necrosis factor-alpha assay for tuberculous pleurisy: A PRISMA-compliant meta-analysis: Erratum
Publicado: (2017) -
Prognostic value of GLUT-1 expression in oral squamous cell carcinoma: A prisma-compliant meta-analysis: Erratum
Publicado: (2017)